Matter for Review
4. "The relationship between business and the research sector, including opportunities to improve Australia’s capacity to capitalise on its investment in health and medical research through commercialisation and strategies for realising returns on Commonwealth investments in health and medical research where gains result from commercialisation."
Returns on NHMRC funded Research and Development, Australian Society for Medical Research, October 2011
“The findings of this report suggest NHMRC funded R&D has the potential to avert a significant proportion of the burden of disease in Australia, which is borne primarily by individuals through morbidity and mortality, but also by society through increased demands on health services. “ Dr Emma Parkinson-Lawrence, President, ASMR
Exceptional Returns: The Value of Investing in Health R&D in Australia II, June 2008
“This report estimates the economic value of health R&D in Australia, updating the Access Economics (2003) Exceptional Returns report for the Australian Society for Medical Research (ASMR) in light of recent increases in health R&D expenditures. These increases are reflected in Australian Bureau of Statistics (ABS) data, and the analysis also includes sensitivity analysis, benchmarking of the rates of return and case studies of four specific examples of the wellbeing returns to health R&D. This report was prepared for the Australian Society of Medical Research by Access Economics.” Excerpt from Exceptional Returns: The Value of Investing in Health R&D in Australia II
- Exceptional Returns: The Value of Investing in Health R&D in Australia II - ASMR June 2008 (PDF, 1.6MB)
Exceptional Returns: The Value of Investing in Health R&D in Australia, September 2003
Medical research – what’s it worth?
“This report provides the first quantitative estimates of the economic benefits of public and charitably funded medical research in the UK. Acting on the recommendation of the UK Evaluation Forum, the Wellcome Trust, the Medical Research Council and the Academy of Medical Sciences commissioned this study to develop methodology and calculate the economic benefits of public and charitably funded medical research in the UK.” Excerpt from Wellcome Trust website
NHMRC Development Grants
NHMRC Development Grants provide funding support to individual researchers, research teams, or a HMR company in partnership with a researcher/s to undertake research at the early proof-of-principle or pre-seed stage.
The Scheme supports the commercial development of a product, process, procedure or service that if applied, would result in improved health care, disease prevention or provide health cost savings.
An NHMRC commissioned review of the outcomes of Development Grants is currently in progress to analyse and evaluate the economic outcomes and benefits delivered to government and the Australian people through this scheme. The Review Report is due for completion in March 2012.